NuRAN Lands $10M Non-Dilutive Revolver, Suspends ATM Sales at Depressed Prices
NUR sits 21% above its 52-week low of $0.6.
Summary
NuRAN secured a $10M non-convertible revolving credit facility for working capital and tower construction, with no equity-linked features, so this financing adds no dilution. Management also said no shares have been sold under its US$50M at-the-market program since Sept. 15, 2026, and it has no current intention to use the ATM at present prices — removing the near-term selling overhang that hung over the stock after the H.C. Wainwright agreement. The facility is secured but excludes the African operating subsidiaries, keeping that debt off the tower assets. Management is targeting 125 additional tower activations to reach breakeven. This follows a stretch of dilution-heavy news: a C$100M shelf, a C$7.6M preferred financing alongside a going-concern warning, and the ATM launch. The real test is whether draws are timely and the new sites actually generate the positive operating cash flow management expects.
At the time of this announcement, NUR was trading at $0.72 on NASDAQ in the Technology sector, with a market capitalization of approximately $8.9M. The 52-week trading range was $0.60 to $158.67. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.